Komori
Solekia Limited (9867) · RiskMitigated

Risk of Delays in Orders, Sales and Development Due to COVID-19

First written in FY2020. 9 of 13 entries say "Restated". Latest entry: FY2024-Q3.

13entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2020 – FY2023-Q3MitigatedFY2024-Q1 – FY2024-Q32020: 320202021: 320212022: 320222023: 320232024: 1
Same theme, other companies
Delays in Orders and On-Site Implementation Due to the Prolonged COVID-19 PandemicA theme 44 companies write about · 45 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2024: 5 of 21 companies on the "Worse" side.

9 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 44 companies compared. The sentences above are computed from all 44.
Full recordFilings, disclosures and news, newest first
  1. FY2024-Q3MitigatedAnnual report

    「With the removal of activity restrictions related to COVID-19, the normalisation of economic and social activity accelerated. Supported by a recovery in inbound demand and improved employment and income conditions, the economy showed a gradual recovery.」

    It was stated that the removal of restrictions on activities related to COVID-19 accelerated the normalization of economic and social activity, indicating that the risks of order intake, sales and development delays caused by COVID-19 had declined.
  2. FY2024-Q1MitigatedAnnual report

    「With the legal classification of COVID-19 changing to Class 5 in May 2023, the further normalization of economic and social activity progressed」

    It was stated that economic and social activity had progressed from the phase of restrictions associated with COVID-19 to normalization following the change in its legal classification, indicating that the business-environment risk posed by the disease had declined.
  3. FY2023SoftenedAnnual report

    「Although it is difficult to predict when the impact of COVID-19 will subside, we have determined that, at present, it does not have a material impact on the financial results of the Group. However, the impact of COVID-19 involves many uncertainties and may affect the financial position and operating results for the following consolidated fiscal year.」

    While it was determined that COVID-19 currently has no material impact on financial results, the possibility of an impact in the following fiscal year remains.
  4. FY2023-Q3RestatedAnnual report

    「The company will continue to closely monitor future developments regarding the impact of the spread of COVID-19 on the group’s business and business performance.」

    It is stated that the future impact of COVID-19 on the business and financial results will continue to be closely monitored.
  5. FY2023-Q2RestatedAnnual report

    「The company will continue to closely monitor the future situation regarding the impact of COVID-19 on the group’s business and business performance.」

    The company states that it will continue to closely monitor the situation regarding the impact of COVID-19 on its business and business performance.
  6. FY2023-Q1RestatedAnnual report

    「Changes in the business environment resulting from delays in the containment of COVID-19 may affect the group’s business performance, and the company will continue to closely monitor developments.」

    The company continues to state that delays in the containment of COVID-19 may affect the business environment and business performance, and that it will closely monitor developments.
  7. FY2022-Q3RestatedAnnual report

    「Changes in the business environment resulting from delays in the containment of COVID-19 may affect the group’s business performance, and the company will continue to closely monitor developments.」

    The company continues to state that delays in the containment of COVID-19 may affect the business environment and business performance, and that it will closely monitor developments.
  8. FY2022-Q2RestatedAnnual report

    「The company will continue to closely monitor the future situation regarding the impact of COVID-19 on the group’s business and business performance.」

    The company states that it will continue to closely monitor the situation regarding the impact of COVID-19 on its business and business performance.
  9. FY2022-Q1RestatedAnnual report

    「Changes in the business environment resulting from delays in the containment of COVID-19 may affect the group’s business performance, and the company will continue to closely monitor developments.」

    The company continues to state that delays in the containment of COVID-19 may affect the business environment and business performance, and that it will closely monitor developments.
  10. FY2021-Q3RestatedAnnual report

    「Changes in the business environment resulting from delays in the containment of COVID-19 may affect the group’s business performance, and the company will continue to closely monitor developments.」

    The company continues to state that delays in the containment of COVID-19 may affect the business environment and business performance, and that it will closely monitor developments.
  11. FY2021-Q2RestatedAnnual report

    「Changes in the business environment resulting from delays in the containment of COVID-19 may affect the group’s business performance, and the company will continue to closely monitor developments.」

    The company continues to state that delays in the containment of COVID-19 may affect the business environment and business performance, and that it will closely monitor developments.
  12. FY2021-Q1RestatedAnnual report

    「Changes in the business environment resulting from delays in the containment of COVID-19 may affect the group’s business performance, and the company will continue to closely monitor developments.」

    The company continues to state that delays in the containment of COVID-19 may affect the business environment and business performance, and that it will closely monitor developments.
  13. FY2020First statedAnnual report

    「As COVID-19 spread globally, suppliers’ and customers’ business performance may deteriorate, leading to delays in orders and sales, schedule delays for projects under system development, and possible project downsizing.」

    The company disclosed for the first time, as a standalone risk item, the potential specific impacts of COVID-19, including deterioration in suppliers’ and customers’ business performance, delays in orders and sales, delays in development projects, and project downsizing. Toward the end of the fiscal year, it also disclosed impacts on people’s lives and corporate activities and a sharp economic slowdown, stating that the impacts had actually occurred.
Moved together

"Recognition of Provision for Loss on Orders" moved the same way as this thread, in the same document, in 3 of its 13 moves.

32222★12345
  1. ★This thread
  2. 1Recognition of Provision for Loss on Orders3×
  3. 2Orders for Electronic Medical Records and Medical Information Systems2×
  4. 3Improving the Equity Ratio and Raising Funds Through Bank Borrowings2×
  5. 4Declining Sales and Wider Losses2×
  6. 5Growth in Operating Cash Flow and Cash Balances2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Solekia Limited yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of Delays in Orders, Sales and Development Due to COVID-19 | Solekia Limited (9867) | Komori